PROVECTUS BIOPHARMACEUTICALS, INC. Cash and Cash Equivalents
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) had Cash and Cash Equivalents of $1.16 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $1.16M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $223.88K.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $251.29K.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $72.48K.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $1.16M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $223.88K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $251.29K 10-K · filed 2026-03-26 |
| 2025-09-30 | $72.48K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $385.93K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $390.44K 10-Q · filed 2026-05-14 |
| 2024-12-31 | $307.44K 10-K · filed 2026-03-26 |
| 2024-09-30 | $187.46K 10-Q · filed 2025-11-13 |
| 2024-06-30 | $29.58K 10-Q · filed 2025-08-14 |
| 2024-03-31 | $18.04K 10-Q · filed 2025-05-14 |
| 2023-12-31 | $76.58K 10-K · filed 2025-03-28 |
| 2023-09-30 | $367.25K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $176.01K 10-Q · filed 2024-08-13 |
| 2023-03-31 | $34.15K 10-Q · filed 2024-05-14 |
| 2022-12-31 | $21.61K 10-K · filed 2024-03-28 |
| 2022-09-30 | $67.03K 10-Q · filed 2023-11-14 |
| 2022-06-30 | $84.27K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $173.61K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $682.98K 10-K · filed 2023-03-30 |
| 2021-09-30 | $254.08K 10-Q · filed 2022-11-09 |
| 2021-06-30 | $47.41K 10-Q · filed 2022-08-11 |
| 2021-03-31 | $349.77K 10-Q · filed 2022-05-12 |
| 2020-12-31 | $97.23K 10-K · filed 2022-03-29 |
| 2020-09-30 | $986.52K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.48M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $213.74K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $590.71K 10-K · filed 2021-03-02 |
| 2019-09-30 | $434.79K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.32M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.77M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $50.99K 10-K · filed 2020-03-05 |
| 2018-09-30 | $231.92K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $130.63K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $244.10K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $105.50K 10-K · filed 2019-03-07 |
| 2017-09-30 | $208.28K 10-Q · filed 2018-11-08 |
| 2017-06-30 | $1.13M 10-Q · filed 2018-08-07 |
| 2017-03-31 | $436.95K 10-Q · filed 2018-05-09 |
| 2016-12-31 | $1.17M 10-Q · filed 2018-11-08 |
| 2016-09-30 | $5.18M 10-Q · filed 2017-11-08 |
| 2016-06-30 | $4.89M 10-Q · filed 2017-08-09 |
| 2016-03-31 | $9.76M 10-Q · filed 2017-05-10 |
| 2015-12-31 | $14.18M 10-K · filed 2018-03-23 |
| 2015-09-30 | $18.88M 10-Q · filed 2016-11-09 |
| 2015-06-30 | $23.12M 10-Q · filed 2016-08-09 |
| 2015-03-31 | $14.17M 10-Q · filed 2016-05-10 |
| 2014-12-31 | $17.39M 10-K · filed 2017-03-31 |
| 2014-09-30 | $17.77M 10-Q · filed 2015-11-05 |
| 2014-06-30 | $18.13M 10-Q · filed 2015-08-06 |
| 2014-03-31 | $16.65M 10-Q · filed 2015-05-07 |
| 2013-12-31 | $15.70M 10-K · filed 2017-03-31 |
| 2013-09-30 | $8.25M 10-Q · filed 2014-11-06 |
| 2013-06-30 | $4.64M 10-Q · filed 2014-08-07 |
| 2013-03-31 | $4.32M 10-Q · filed 2014-05-08 |
| 2012-12-31 | $1.22M 10-K · filed 2016-03-30 |
| 2012-09-30 | $1.84M 10-Q · filed 2013-11-12 |
| 2012-06-30 | $4.07M 10-Q · filed 2013-08-08 |
| 2012-03-31 | $4.90M 10-Q · filed 2013-05-10 |
| 2011-12-31 | $7.71M 10-K · filed 2015-03-12 |
| 2011-09-30 | $10.81M 10-Q · filed 2012-11-08 |
| 2011-06-30 | $14.39M 10-Q · filed 2012-08-08 |
| 2011-03-31 | $12.40M 10-Q · filed 2012-05-09 |
| 2010-12-31 | $8.09M 10-K · filed 2014-03-13 |
| 2010-09-30 | $10.04M 10-Q · filed 2011-11-08 |
| 2010-06-30 | $12.51M 10-Q · filed 2011-08-09 |
| 2009-12-31 | $3.24M 10-K · filed 2013-03-14 |
| 2008-12-31 | $2.80M 10-K · filed 2012-03-14 |